BeiGene Future Growth
Future criteria checks 4/6
BeiGene is forecast to grow earnings and revenue by 62.5% and 19.6% per annum respectively. EPS is expected to grow by 67.1% per annum. Return on equity is forecast to be 16.7% in 3 years.
Key information
62.5%
Earnings growth rate
67.1%
EPS growth rate
| Biotechs earnings growth | 30.0% |
| Revenue growth rate | 19.6% |
| Future return on equity | 16.7% |
| Analyst coverage | Good |
| Last updated | 23 Aug 2024 |
Recent future growth updates
Recent updates
BeiGene: Poised For Re-Rating As BTKi Sales Show Strong Beat
Aug 22Analysts Just Made An Incredible Upgrade To Their BeiGene, Ltd. (NASDAQ:BGNE) Forecasts
Aug 14
BeiGene, Ltd. (NASDAQ:BGNE) Shares Fly 27% But Investors Aren't Buying For Growth
Aug 09BeiGene: Navigating Patent Disputes Towards Profitability (Rating Upgrade)
Jun 21We Think Some Shareholders May Hesitate To Increase BeiGene, Ltd.'s (NASDAQ:BGNE) CEO Compensation
May 30Is BeiGene (NASDAQ:BGNE) Using Too Much Debt?
Apr 21BeiGene Still Bleeding Red Ink Despite Blockbuster Drug
Mar 08BeiGene, Ltd.'s (NASDAQ:BGNE) Intrinsic Value Is Potentially 26% Above Its Share Price
Jan 31Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money
Oct 16Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:BGNE) 39% Undervaluation?
Jul 11Rock star Growth Puts BeiGene (NASDAQ:BGNE) In A Position To Use Debt
Jun 19Revenues Not Telling The Story For BeiGene, Ltd. (NASDAQ:BGNE)
Apr 17A Look At The Fair Value Of BeiGene, Ltd. (NASDAQ:BGNE)
Mar 24Is BeiGene (NASDAQ:BGNE) Using Debt Sensibly?
Dec 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5,609 | 403 | 305 | 731 | 25 |
| 12/31/2025 | 4,534 | -154 | -318 | 44 | 29 |
| 12/31/2024 | 3,633 | -672 | -609 | -285 | 26 |
| 6/30/2024 | 3,097 | -524 | -1,356 | -704 | N/A |
| 3/31/2024 | 2,763 | -784 | -1,566 | -902 | N/A |
| 12/31/2023 | 2,459 | -882 | -1,754 | -1,157 | N/A |
| 9/30/2023 | 2,204 | -959 | -1,853 | -1,254 | N/A |
| 6/30/2023 | 1,811 | -1,732 | -2,283 | -1,738 | N/A |
| 3/31/2023 | 1,557 | -1,917 | -2,298 | -1,824 | N/A |
| 12/31/2022 | 1,416 | -2,004 | -1,966 | -1,497 | N/A |
| 9/30/2022 | 1,250 | -2,149 | -2,144 | -1,686 | N/A |
| 6/30/2022 | 1,069 | -2,030 | -2,016 | -1,620 | N/A |
| 3/31/2022 | 877 | -1,960 | -2,044 | -1,660 | N/A |
| 12/31/2021 | 1,176 | -1,458 | -1,614 | -1,299 | N/A |
| 9/30/2021 | 1,062 | -1,340 | -1,334 | -1,123 | N/A |
| 6/30/2021 | 947 | -1,327 | -1,193 | -974 | N/A |
| 3/31/2021 | 863 | -1,167 | -1,030 | -816 | N/A |
| 12/31/2020 | 309 | -1,625 | -1,510 | -1,283 | N/A |
| 9/30/2020 | 266 | -1,512 | -1,426 | -1,218 | N/A |
| 6/30/2020 | 225 | -1,394 | -1,301 | -1,137 | N/A |
| 3/31/2020 | 402 | -1,145 | -1,093 | -920 | N/A |
| 12/31/2019 | 428 | -949 | -909 | -750 | N/A |
| 9/30/2019 | 430 | -829 | -876 | -677 | N/A |
| 6/30/2019 | 434 | -665 | -747 | -544 | N/A |
| 3/31/2019 | 244 | -737 | -787 | -615 | N/A |
| 12/31/2018 | 198 | -674 | -689 | -548 | N/A |
| 9/30/2018 | 158 | -505 | -344 | -260 | N/A |
| 6/30/2018 | 324 | -243 | -189 | -121 | N/A |
| 3/31/2018 | 271 | -147 | N/A | -56 | N/A |
| 12/31/2017 | 238 | -93 | N/A | 13 | N/A |
| 9/30/2017 | 220 | -31 | N/A | -107 | N/A |
| 6/30/2017 | N/A | -184 | N/A | -138 | N/A |
| 3/31/2017 | 0 | -148 | N/A | -105 | N/A |
| 12/31/2016 | 1 | -119 | N/A | -90 | N/A |
| 9/30/2016 | 6 | -109 | N/A | -80 | N/A |
| 6/30/2016 | 7 | -87 | N/A | -66 | N/A |
| 3/31/2016 | 8 | -69 | N/A | -56 | N/A |
| 12/31/2015 | 9 | -57 | N/A | -40 | N/A |
| 9/30/2015 | 6 | -34 | N/A | -34 | N/A |
| 6/30/2015 | 11 | -29 | N/A | -19 | N/A |
| 3/31/2015 | 12 | -26 | N/A | -11 | N/A |
| 12/31/2014 | 13 | -18 | N/A | -9 | N/A |
| 12/31/2013 | 11 | -7 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BGNE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: BGNE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BGNE is expected to become profitable in the next 3 years.
Revenue vs Market: BGNE's revenue (19.6% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: BGNE's revenue (19.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BGNE's Return on Equity is forecast to be low in 3 years time (16.7%).